Work

Genetic Representation in Parkinson's Research Drives Progress

Year: 2026

Type: article

Abstract: Despite decades of genetic studies, less than 5% of Parkinson’s disease research published since 2000 has examined race and ethnicity as an integral part of analysis, leaving major gaps in our understanding of disease development, symptom heterogeneity, and treatment efficacy across diverse populations. This article describes how the Global Parkinson's Genetics Program (GP2) is systematically addressing this disparity, demonstrating how greater representation in genetic studies paves the way to precision treatment and better understanding of disease etiology across the world.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.20804333

Authors: Klinger, Madeline, Lewis, Dana, Snyder, Devin, Blauwendraat, Cornelis, Dumanis, Sonya

Institutions: Aligning Science Across Parkinson's, Coalition for Aligning Science

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDGs: Reduced inequalities, Good health and well-being

Open Access status: green

OpenAlex ID: W7165534549

FWCI:

Cites:

Cited by:

Related to: 10